Stress during menopause may accelerate liver damage and metabolic disorders

Emerging research suggests that prolonged stress during the menopause transition can elevate cortisol levels, strain the liver, and increase risk of metabolic diseases such as fatty liver, highlighting the need for stress management in women’s health.

Stress may do more than leave people feeling exhausted; it can also affect the liver in ways that matter during the menopause transition. In material published by My Menopause Transformation, the focus is on how long-running stress can keep cortisol elevated, push the body into a persistent fight-or-flight state and alter glucose handling. The result, the piece argues, is a pattern that can gradually place extra strain on the liver and on overall metabolic health.

That concern is supported by medical literature. A review indexed in PubMed in 2019 found that psychological stress can damage liver tissue through several pathways, including oxidative stress, reduced blood flow and signals from the sympathetic nervous system and adrenal hormones. Another review, also indexed in PubMed, linked psychosocial stress with the progression of liver disease and described how stress can disrupt the hypothalamic-pituitary-adrenal axis and immune function, worsening existing hepatic conditions.

The broader science suggests the liver is deeply connected to the nervous system. Research published in 2004 found that sympathetic nerve fibres interact with hepatic stellate cells, which are involved in repair and scarring. More recent work has described how the liver’s sympathetic wiring can change under metabolic stress, while a Nature Index review has highlighted the liver as a site where autonomic signals help regulate metabolism, inflammation and regeneration.

Against that backdrop, the menopause article warns that women entering perimenopause or menopause may already be dealing with poor sleep, emotional strain and hormonal change, all of which can add to the burden on the liver. It also points to the risk of fatty liver disease, including non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease, particularly where blood tests show raised liver enzymes. The article closes with a personal example from Peta, a competitive triathlete and coach, who said, “I’d lost all my mojo and drive to train. Getting out of bed was hard enough. All the reading I had done had told me that my oestrogen levels were dropping in peri-menopause, so I was stuffing myself with oestrogen products but Wendy’s programme told me I was feeding myself stuff that was making my liver health worse – and the stress o training and lack of sleep and everything plus feeding myself high protein (eggs etc) sports nutrition foods, had turned my body into a cocktail of hormones.”